RECRUITINGOBSERVATIONAL

Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®

Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®: the GRANITE Study (Glaucoma tReatment AdhereNce wIth connecTed dEvice in Italy)

About This Trial

The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP® The main questions it aims to answer are: * The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient * The adherence profile of each patient * The association between the adherence profile, the objective adherence data and the clinical data. Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.

Who May Be Eligible (Plain English)

Who May Qualify: - Adult patient (≥ 18 years old), man or woman - Patient with a diagnosis of bilateral open angle glaucoma - Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy. - Patient willing to participate in the study - Patient who consents for data collection in the frame of the study Who Should NOT Join This Trial: - Pregnant and/or lactating woman - Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months) - Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Adult patient (≥ 18 years old), man or woman * Patient with a diagnosis of bilateral open angle glaucoma * Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy. * Patient willing to participate in the study * Patient who consents for data collection in the frame of the study Exclusion Criteria: * Pregnant and/or lactating woman * Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months) * Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision

Locations (17)

Besomed SRLS

Bari, Italy

Studio Oculistico D'Azeglio

Bologna, Italy

Centro Medico Polispecialistico Di Maita

Catania, Italy

Studio Medico Oculistico Dr.ssa Rosa SCHIAVELLI s.r.l.

Corigliano, Italy

Ospedale Policlinico S. Martino-IRCCS Clinica Oculistica Università di Genova

Genova, Italy

Poliambulatorio Chirurgico Modenese Eyecare Clinic

Modena, Italy

Centro Oculistico Ramovecchi S.r.l.

Morrovalle, Italy

AOU Federico II di Napoli Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche Università degli studi di Napoli Federico II U.O.C. di Oftalmologia

Naples, Italy

Azienda Ospedale-Università Padova Ospedale Sant'Antonio UOC Oculistica

Padova, Italy

A.O.U. Pisana UO Oculistica Universitaria

Pisa, Italy

Ambulatorio Oculistica Ospedale San Carlo di Nancy -GVM-

Roma, Italy

Fondazione PTV Policlinico Tor Vergata Fondazione PTV Policlinico Tor Vergata UOSD di Oculistica

Roma, Italy

IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS Presidio Ospedaliero Britannico Unità di Ricerca "Glaucoma

Roma, Italy

AULSS 4 Veneto Orientale Ospedale di San Donà di Piave Dip. Oculistica

San Donà di Piave, Italy

AOU Sassari Clinica Oculistica

Sassari, Italy

Studi Oculistici

Seravezza, Italy

Humanitas Gradenigo U.O. Oculistica

Torino, Italy